Home
Market News
Breaking stock market headlines
Earnings Flash
Breaking coverage of earnings reports, forecasts & dividend updates
Trends
Market movers, trading patterns & key market indicators
Disclosures
Official filings & reports from listed Japanese companies
Explorer
Stock lists filtered by fundamental & technical metrics
Japan Medical Dynamic Marketing, 14% Increase in Ordinary Profit for The Current Fiscal Year, Dividend Raised by 2 yen
7600 Japan Medical Dynamic Marketing, INC. 【J-GAAP】
Earnings ReportJapan Medical Dynamic Marketing, INC. <7600> [TSE Prime] announced its financial results at noon (12:30) on April 30th. The consolidated ordinary profit for the fiscal year ending March 2025 decreased 19.2% from the previous period to 1.48 billion yen. In the fiscal year ending March 2026, the profit is expected to grow by 14.2% to 1.7 billion yen. This will be the fifth consecutive term of revenue growth.
At the same time, the company has decided to increase the dividend this fiscal year to 17 yen, an increase of 2 yen from the previous fiscal year.
In the most recent three-month period, from January to March (4Q), the consolidated ordinary profit significantly dropped to 0.29 billion yen, a 52.4% decrease compared to the same period last year. The operating profit margin drastically worsened from 9.1% in the same period last year to 4.9%.
Kabutan News
Actual Results
Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Adj. Dividend | Announce | Accounting Standards |
---|---|---|---|---|---|---|---|---|
Mar, 2023 | 21,307 | 2,024 | 2,043 | 1,423 | 54.0 | 13 | Apr 28, 2023 | J-GAAP |
Mar, 2024 | 23,177 | 1,746 | 1,842 | 1,271 | 48.3 | 14 | Apr 30, 2024 | J-GAAP |
Mar, 2025 | 25,114 | 1,555 | 1,488 | -461 | -17.5 | 15 | Apr 30, 2025 | J-GAAP |
YoY | +8.4% | -10.9% | -19.2% | - | - |
Full Year Results vs. Previous Guidance
Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Adj. Dividend | Announce | Accounting Standards |
---|---|---|---|---|---|---|---|---|
Mar, 2025 Guidance | 25,000 | 1,500 | 1,460 | -250 | -9.5 | 15 | Mar 27, 2025 | J-GAAP |
Mar, 2025 Results | 25,114 | 1,555 | 1,488 | -461 | -17.5 | 15 | Apr 30, 2025 | J-GAAP |
Revision Rate | +0.5% | +3.7% | +1.9% | -84.4% | -84.8% |
Current Period Guidance
H1 Results
Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Adj. Dividend | Announce | Accounting Standards |
---|---|---|---|---|---|---|---|---|
Apr - Sep, 2024 | 11,817 | 669 | 664 | 496 | 18.9 | 0 | Oct 30, 2024 | J-GAAP |
Apr - Sep, 2025 Guidance | 12,250 | 600 | 500 | 350 | 13.3 | 0 | Apr 30, 2025 | J-GAAP |
YoY | +3.7% | -10.3% | -24.7% | -29.4% | -29.5% |
Current Period Guidance
Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Adj. Dividend | Announce | Accounting Standards |
---|---|---|---|---|---|---|---|---|
Mar, 2024 | 23,177 | 1,746 | 1,842 | 1,271 | 48.3 | 14 | Apr 30, 2024 | J-GAAP |
Mar, 2025 | 25,114 | 1,555 | 1,488 | -461 | -17.5 | 15 | Apr 30, 2025 | J-GAAP |
Mar, 2026 Guidance | 26,400 | 1,850 | 1,700 | 1,450 | 55.1 | 17 | Apr 30, 2025 | J-GAAP |
YoY | +5.1% | +19.0% | +14.2% | - | - |
Quarterly Results
Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Operating Profit Margin | Announce | Accounting Standards |
---|---|---|---|---|---|---|---|---|
Jan - Mar, 2024 | 6,184 | 563 | 617 | 539 | 20.5 | 9.1 | Apr 30, 2024 | J-GAAP |
Apr - Jun, 2024 | 6,052 | 366 | 367 | 273 | 10.4 | 6.0 | Jul 30, 2024 | J-GAAP |
Jul - Sep, 2024 | 5,765 | 303 | 297 | 223 | 8.5 | 5.3 | Oct 30, 2024 | J-GAAP |
Oct - Dec, 2024 | 6,641 | 560 | 530 | 383 | 14.6 | 8.4 | Jan 30, 2025 | J-GAAP |
Jan - Mar, 2025 | 6,656 | 326 | 294 | -1,340 | -51.0 | 4.9 | Apr 30, 2025 | J-GAAP |
YoY | +7.6% | -42.1% | -52.4% | - | - |
Related Articles
TRUSCO NAKAYAMA, Jan-Mar (1Q) Ordinary Profit Increases by 15%
HARIMA CHEMICALS, 50% Increase in Ordinary Profit for The Current Fiscal Year
BroadBand Tower, Jan-Mar (1Q) Ordinary Profit Decreases by 17%
Okura Industrial, Jan-Mar (1Q) Ordinary Profit Increases by 23%
NIHON SHOKUHIN KAKO, 6% Decrease in Ordinary Profit for The Current Fiscal Year, Increased Previous Year's Dividend by 15 yen, This Fiscal Year to Increase Dividend by 50 yen
Cytori Cell Research Institute, Last Fiscal Year Net Income Loss Widened in Downward Revision, 77% Deficit Against Net Assets
Mitsui O.S.K.Lines, 64% Decrease in Ordinary Profit for The Current Fiscal Year, Despite Last Fiscal Year's Dividend Increase, This Fiscal Year to Decrease Dividend
Arealink, Jan-Mar (1Q) Ordinary Profit Increases by 11%
TAIYO HOLDINGS, 4% Increase in Ordinary Profit, Update Record High for Second Consecutive Term, Dividend Raised by 100 yen
NAIGAI TRANS LINE, Jan-Mar (1Q) Ordinary Profit Decreases by 18%